Board of Trustees of The Leland Stanford Junior University’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-58,492	Closed	-$1.12M	–	43
2022 Q1	$1.12M	Sell	58,492 -175,422	-75%	-$3.13M	0.06%	23
2021 Q4	$5.92M	Hold	233,914	–	–	0.37%	14
2021 Q3	$7.66M	Buy	+233,914	New	+$7.97M	0.57%	15

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's DICE Position: Q2 2022 in Review

Board of Trustees of The Leland Stanford Junior University sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2022, closing a stake of 58,492 shares — an estimated $1.12M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in DICE in Q3 2021 and held it in 3 quarters. The position peaked at $7.66M in Q3 2021. 80 funds tracked by Wall St. Rank hold DICE as of Q2 2022.

Board of Trustees of The Leland Stanford Junior University reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 58,492 DICE Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $1.12M.
Board of Trustees of The Leland Stanford Junior University first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
Board of Trustees of The Leland Stanford Junior University's DICE Therapeutics, Inc. Common Stock position peaked at $7.66M in Q3 2021.
80 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q2 2022, filed 12 Aug 2022.